Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2331871A1 Novel formulation containing paroxetine
11/18/1999CA2331866A1 Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides
11/18/1999CA2331849A1 Novel formulation containing paroxetine
11/18/1999CA2331735A1 Phenylurea and phenylthio urea derivatives
11/18/1999CA2331631A1 Benzocarbazoles and indenoindoles as estrogenic agents
11/18/1999CA2331620A1 Use of neomycin for treating angiogenesis-related diseases
11/18/1999CA2331584A1 Morpholino ethers
11/18/1999CA2331542A1 Antidepressant therapy
11/18/1999CA2331501A1 Therapeutic compositions
11/18/1999CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999CA2331350A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
11/18/1999CA2331315A1 Identification of molecular interaction sites in rna for novel drug discovery
11/18/1999CA2331299A1 Substituted guanidines and diaminonitroethenes, their preparation and use
11/18/1999CA2331295A1 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
11/18/1999CA2331120A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2331118A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330812A1 Epothilone derivatives, a method for the production thereof, and their use
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2330741A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
11/18/1999CA2330623A1 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330599A1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330558A1 (2-acylaminothiazole-4-yl)acetic acid derivatives
11/18/1999CA2330557A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999CA2330555A1 Naphtho[2,3-b]heteroar-4-yl derivatives
11/18/1999CA2330484A1 1-galactose derivatives
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2328965A1 Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same
11/18/1999CA2328601A1 Preventives/remedies for hepatic cirrhosis
11/18/1999CA2328521A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
11/18/1999CA2328520A1 Use of anti-prolactin agents to treat proliferative conditions
11/18/1999CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis
11/18/1999CA2328414A1 Methods for detecting and inhibiting angiogenesis
11/18/1999CA2328406A1 Methods for regulating hematopoiesis using cpg-oligonucleotides
11/18/1999CA2327386A1 Inhibition of protein kinases with piridinylimidazoles
11/18/1999CA2327345A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
11/18/1999CA2326105A1 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol
11/18/1999CA2325636A1 Oral medicinal forms with reproducible release of the active ingr edient gatifloxacin or its pharmaceutically acceptable salts or hydrates
11/17/1999EP0957173A1 Process for preparing fat or oil containing unsaturated fatty acid
11/17/1999EP0957172A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
11/17/1999EP0957103A1 Oxazolidinone derivatives useful as antiarrhythmic and antifibrillatory agents
11/17/1999EP0957102A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/17/1999EP0957101A1 Water soluble azoles as broad-spectrum antifungals
11/17/1999EP0957100A1 Diamine derivatives and pharmaceutical containing the same
11/17/1999EP0957099A2 Heterocyclic carboxamides
11/17/1999EP0957094A1 1-(2-Halogenaryl)azoles as antiparasitic agents
11/17/1999EP0957093A2 Retrovial protease inhibitors
11/17/1999EP0957092A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions
11/17/1999EP0957091A1 Inhibitors of tumor necrosis factor alpha
11/17/1999EP0957088A1 Vitamin d3 derivatives and process for producing the same
11/17/1999EP0957087A2 Enzyme inhibitors
11/17/1999EP0957080A1 Novel ethylamine derivatives
11/17/1999EP0957073A1 Novel derivatives of 3,3-diphenylpropylamines
11/17/1999EP0956869A2 Tissue sealant
11/17/1999EP0956867A1 Use of flavonoid glycosides, tanning agents and microorganisms for the therapy and prophylaxis of diabetes mellitus
11/17/1999EP0956866A1 Drugs for ameliorating ophthalmic circulatory disturbance
11/17/1999EP0956865A1 MEDICINES COMPRISING Rho KINASE INHIBITOR
11/17/1999EP0956862A1 Methods of increasing lean tissue mass using ob protein compositions
11/17/1999EP0956861A1 Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having chronic hepatitis c infection
11/17/1999EP0956858A1 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
11/17/1999EP0956857A2 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
11/17/1999EP0956856A2 Calcium assimilation accelerator, calcium supplementing diet and method for accelerating calcium assimilation
11/17/1999EP0956855A1 Immunosuppressive effects of 8-substituted xanthine derivatives
11/17/1999EP0956854A1 Pharmaceutical composition comprising coenzyme q 10
11/17/1999EP0956852A2 Skin external preparation
11/17/1999EP0956352A1 A polynucleotide herpes virus vaccine
11/17/1999EP0956301A2 Il-12 gene expression and delivery systems and uses
11/17/1999EP0956287A1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function
11/17/1999EP0956285A1 Novel genipin derivative having anti hepatitis b virus activity
11/17/1999EP0956281A1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound
11/17/1999EP0956048A1 Stable compositions containing biologically active components
11/17/1999EP0956046A2 Cellular vaccines and immunotherapeutics and methods for their preparation
11/17/1999EP0956043A1 Strain selection of pneumococcal surface proteins
11/17/1999EP0956040A1 Stimulation of host defense mechanisms against viral challenges
11/17/1999EP0956037A1 Agents for the regulation of oestrogen synthesis
11/17/1999EP0956035A1 Oral cyclosporin formulations
11/17/1999EP0956034A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
11/17/1999EP0956031A1 Inhibition of 26s and 20s proteasome by indanones
11/17/1999EP0956027A1 Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk
11/17/1999EP0956026A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
11/17/1999EP0956024A1 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
11/17/1999EP0956023A1 Progesterone for treating or reducing ischemia
11/17/1999EP0956022A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound
11/17/1999EP0956021A1 L-$g(b)-DIOXOLANE URIDINE ANALOGS AND METHODS FOR TREATING AND PREVENTING VIRUS INFECTIONS
11/17/1999EP0956020A1 Use of 2-(4-methoxyphenyl)-pyrazolo(4,3-c)quinolin-3-one in the manufacture of a medicament for enhancing cognition
11/17/1999EP0956019A1 Novel therapeutic application of a thienycyclohexylamine derivative
11/17/1999EP0956017A1 Benzimidazole-2-carbamates for the treatment of viral infections and cancer
11/17/1999EP0956016A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
11/17/1999EP0956015A1 A pharmaceutical composition containing kynurenine and thymine or tryptophan and thymine
11/17/1999EP0956014A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
11/17/1999EP0956013A1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
11/17/1999EP0956012A1 Fatty acid treatment
11/17/1999EP0956011A1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
11/17/1999EP0956010A1 Pharmaceutical microspheres of valproic acid for oral administration
11/17/1999EP0956009A1 Treatment of neurodegenerative conditions with nimesulide
11/17/1999EP0956007A1 Chewing gum containing colloidal bismuth subcitrate
11/17/1999EP0956006A1 Colonic delivery of weak acid drugs
11/17/1999EP0956002A1 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes
11/17/1999EP0956001A1 PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT $i(IN VIVO) DELIVERY
1 ... 6410 6411 6412 6413 6414 6415 6416 6417 6418 6419 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 6430 ... 7860